Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes

Surgery Today

Volumn 42, Issue 7, 2012, Pages 652-658

  Nakatsu, Toshinobu ^a   Motoyama, Satoru ^a   Maruyama, Kiyotomi ^a   Usami, Shuetsu ^a   Sato, Yusuke ^a   Miura, Masatomo ^b   Hinai, Yudai ^b   Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Murata, Katsuyuki ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CRP; Esophageal cancer; Prognosis; Recurrence; Tumoral expression

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE RISK; SEX DIFFERENCE; SURVIVAL RATE; THORACIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 84863983180     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0147-3     Document Type: Article

References (28)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420:860-7. (Pubitemid 36019639)
2. Vakkila J, Lotze MT. Inflammation and necrosis promote tumor growth. Nat Rev Immunol. 2004;4:641-8. (Pubitemid 39025049)
3. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117: 104-11. (Pubitemid 41407719)
4. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487-90. (Pubitemid 39625721)
5. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive proteinand the risk of incident colorectal cancer. JAMA. 2004;291: 585-90. (Pubitemid 38500312)
6. Crumely AB, Mcmillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006;94:1568-71. (Pubitemid 43924914)
7. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer. 2005;103:1856-64. (Pubitemid 40563258)
8. Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008;14:710-4. (Pubitemid 351231151)
9. Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, Coulocheri SA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancerrelated thrombocytosis. Am J Clin Oncol. 2003;26:135-40. (Pubitemid 36443554)
10. Jabs WJ, Busse M, Kruger S, Jocham D, Steinhoff J, Doehn C. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int. 2005;68: 2103-10. (Pubitemid 43117784)
11. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K. Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus-significance as a tumor marker. Cancer Lett. 2003;192:89-95. (Pubitemid 36287664)
12. Lu G, Liao J, Yang G, Reuhl KR, Hao X, Yang CS. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)- 1-(3-pyridyl)-1- butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006;66:11494-501. (Pubitemid 46009983)
13. Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, Hoon DSB. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics. 2011;6:388-94.
14. Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, et al. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann Surg Oncol. 2006;13:1724-31. (Pubitemid 44951483)
15. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001;38:189-97. (Pubitemid 32786776)
16. Jabs WJ, Lögering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol. 2003;33:152-61. (Pubitemid 36157653)
17. Gould JM, Weiser JN. Expression of C-reactive protein in the human respiratory tract. Infect Immun. 2001;69:1747-54. (Pubitemid 32187634)
18. Klein L, Klein T, Ruther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med. 1998;188:5-16. (Pubitemid 28328601)
19. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671-4. (Pubitemid 36222590)
20. Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation. 2003;108:1428-31. (Pubitemid 37176446)
21. Yasojima K, Schwab C, Mcgeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 2000;887:80-9. (Pubitemid 32008026)
22. Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med. 1986;164:321.
23. Egenhofer C, Alsdorff K, Fehsel K, Kolb-Bachofen V. Membrane associated C-reactive protein on rat liver macrophages is synthesized within the macrophages, expressed as neo-C-reactive protein and bound through a C-reactive protein-specific membrane receptor. Hepatology. 1993;18:1216.
24. Kolh-Bachofen V, Puchtateudt N, Egenhofer C. Expression of membrane-associated C-reactive protein by human monocytes: indications for a selectin-like activity participating in adhesion. Glycoconj J. 1995;12:122.
25. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus. 2005;18:146-50. (Pubitemid 41801107)
26. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2003;83:248-52. (Pubitemid 36936011)
27. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg. 2001;182:197-201. (Pubitemid 32907362)
28. Kundu JK, Surth YJ. Inflamation: generation the journey to cancer. Mutat Res. 2008;659:15-30.